EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression

Lesly Acosta, Núria Soldevila iD, Núria Torner iD, Ana Avellón, Victoria Hernando, Eva Borràs, Ana Martínez, Carles Pericas, Cristina Rius, Pere Godoy, Angela Domínguez

PLOS One · 23.06.2026 · 21 (6) · e0329751

DOI: 10.1371/journal.pone.0329751 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 23.06.2026. Verfasst von Lesly Acosta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Universitat Politècnica de Catalunya· Barcelona Tech, Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic hepatitis B (CHB) virus infection leads to severe complications, cirrhosis and hepatocellular carcinoma (HCC). The main objective of this study was to develop an ARIMA-based model to forecast the progression of global hospital discharges, due to cirrhosis and HCC related to chronic hepatitis B.

Methods

Retrospective observational study of monthly incidence of CHB related hospitalization discharges from 2005 to 2021 in Spain. Data were obtained through the Spanish Minimum dataset of hospital discharge registry (CMBDH) of the Health Ministry. Main diagnosis of CHB, liver cirrhosis and HCC encoded by International Medical codes (ICM–9 and ICM-10) were used. Descriptive and time series analysis was performed with forecasts made for 2022 using seasonal ARIMA and ARIMAX models. Data stationarity was achieved via a square root Box-Cox transformations and differencing. Model selection used was AIC, BIC, MAPE, and forecasting precision. Analysis was performed in R (version 4.5.0).

Results

The total number of discharges related to hepatitis B was 6743, 58% were due to HCC and 42% to cirrhosis diagnosis. Median age was 59 years (range: 7 to > 100), being 83.4% men. The global chronic hepatitis B (CHB) related workload values range from 10 to 55 monthly discharges, while hepatitis B related to HCC and cirrhosis range from 4 to 34 and 1–29 discharges, respectively. The best fit and 2022 forecasts found for CHB and HCC time series was obtained with the approximate Gaussian Y -ARIMAX (6,0,0) (0,1,1) _12 model. This model after treating outliers, removes seasonal patterns and captures the series’ autoregressive dynamics with an AR(6) and seasonal MA(1) noise with expression: ( 1 − ϕ 1 B − ϕ 2 B 2 − . . . − ϕ 6 B 6 ) ( y t − y t − 1 2 ) = ε t + Θ 1 ε t − 1 2 with ε ~ N(0, σ²) and in the square root scale.

Conclusion

Both ARIMA and ARIMAX models play critical roles in forecasting CHB-related HCC and cirrhosis, enabling better disease monitoring, healthcare resources, and intervention assessment. ARIMAX provided more accurate context-aware predictions, making it especially valuable for public health decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver CirrhosisHepatitis B, ChronicLiver NeoplasmsPatient DischargeHepatitis B virusSpainHumansRetrospective StudiesMaleFemaleMiddle AgedAdultAgedDisease ProgressionAged, 80 and overForecastingChild

Autor:innen und Institutionen

  • Universitat Politècnica de Catalunya· Barcelona Tech, Barcelona, Spain.
  • CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Medicine. University of Barcelona, Barcelona, Spain.
  • Hepatitis Unit, National Centre of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Centro Nacional de Epidemiología. Instituto de Salud Carlos III, Madrid, Spain.
  • CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Núria Soldevila, Núria Torner

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Acosta, L., Soldevila, N., Torner, N., Avellón, A., Hernando, V., Borràs, E., Martínez, A., Pericas, C., Rius, C., Godoy, P., & Domínguez, A. (2026). Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression. PLOS One, 21(6), e0329751. https://doi.org/10.1371/journal.pone.0329751

Vancouver

Acosta L, Soldevila N, Torner N, Avellón A, Hernando V, Borràs E, et al. Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression. PLOS One. 2026;21(6):e0329751. doi:10.1371/journal.pone.0329751

BibTeX
@article{Acosta2026,
  author = {Acosta, Lesly and Soldevila, Núria and Torner, Núria and Avellón, Ana and Hernando, Victoria and Borràs, Eva and Martínez, Ana and Pericas, Carles and Rius, Cristina and Godoy, Pere and Domínguez, Angela},
  title = {Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0329751},
  doi = {10.1371/journal.pone.0329751}
}
Kostenlos starten →